Gainers
- Processa Pharma PCSA shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million.
- Cyclacel Pharmaceuticals CYCC stock rose 23.04% to $2.83. The company's market cap stands at $3.7 million.
- Compass Therapeutics CMPX shares rose 21.62% to $1.8. The market value of their outstanding shares is at $247.6 million.
- Virax Biolabs Group VRAX shares increased by 19.37% to $0.79. The company's market cap stands at $1.8 million.
- Nuwellis NUWE shares increased by 13.84% to $0.29. The company's market cap stands at $1.9 million.
- Can Fite Biofarma CANF stock moved upwards by 12.37% to $2.18. The company's market cap stands at $10.8 million.
Losers
- Sunshine Biopharma SBFM stock decreased by 10.5% to $0.83 during Thursday's pre-market session.
- Vaccinex VCNX shares declined by 8.1% to $4.6. The company's market cap stands at $7.2 million.
- SenesTech SNES stock fell 8.04% to $0.7. The company's market cap stands at $3.6 million.
- Pluri PLUR stock decreased by 7.27% to $4.72. The company's market cap stands at $24.6 million.
- Adial Pharmaceuticals ADIL stock fell 7.02% to $1.59. The market value of their outstanding shares is at $6.4 million.
- Heart Test Laboratories HSCS shares declined by 6.86% to $0.1. The market value of their outstanding shares is at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CANFCan Fite Biofarma Ltd
$1.45-2.03%
CMPXCompass Therapeutics Inc
$1.487.25%
CYCCCyclacel Pharmaceuticals Inc
$0.32863.53%
HSCSHeartSciences Inc
$3.55-7.31%
NUWENuwellis Inc
$1.1010.0%
PCSAProcessa Pharmaceuticals Inc
$0.8137-4.27%
PLURPluri Inc
$4.61-4.36%
SBFMSunshine Biopharma Inc
$2.945.76%
SNESSenesTech Inc
$2.74-6.56%
VCNXVaccinex Inc
$1.318.26%
VRAXVirax Biolabs Group Ltd
$1.908.57%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in